Table of Content - Somatropin Market

Somatropin injections are used to replace growth hormone (a natural hormone produced by the body) in adults and children with growth hormone deficiency. Somatropin injections are also used to increase growth in children with certain conditions that affect normal growth and development. Somatropin injection comes as a solution (liquid) in prefilled dosing pens and cartridges and also as a powder in vials and cartridges to be mixed with liquid to be injected subcutaneously (under the skin). When somatropin injections are given to replace growth hormone in adults, it is usually given once a day. Somatropin injections (Serostim) are used to increase body weight and physical endurance in patients with the human immunodeficiency virus (HIV) who have HIV-associated wasting syndrome. Somatropin injections (Zorbtive) are used to treat short bowel syndrome in adults who are receiving additional nutrition or fluids from intravenous (IV) therapy. Somatropin is a human growth hormone (hGH) analog. It works by replacing growth hormones that are normally produced in the body, which may result in increased growth, body weight, and improved absorption of nutrients and fluids from the intestines. When somatropin injection to replace growth hormone or increase growth in children, it is usually given once daily for 3 to 7 days each week. Increasing product launches or product approvals by the regulatory authorities and an increase in the long term effect of growth hormone therapy on children with growth hormone deficiency are expected to fuel the growth of the global somatropin market over the forecast period.

Market Dynamics

Increasing product approval by regulatory authorities and an increase in the long term effect of growth hormone therapy on children with growth hormone deficiency is expected to fuel growth of the global somatropin market over the forecast period. For instance, in January, 2022, Ascendis Pharma A/S, a company that manufactures pharmaceutical products, announced that the European Commission (EC) granted marketing authorization for Lonapegsomatropin Ascendis Pharma (developed under the name TransCon hGH) as a once-weekly subcutaneous injection for the treatment of children and adolescents aged 3 to 18 years with growth failure due to insufficient secretion of endogenous growth hormone (also known as growth hormone deficiency, or GHD). TransCon hGH is a prodrug of somatropin that provides sustained release of unmodified somatropin (hGH) at predictable therapeutic levels in the body.

Key features of the study:

This report provides in-depth analysis of the global somatropin market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global somatropin market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Novo Nordisk A/S, Pfizer, Inc., Eli Lilly and Company, Changchun GeneScience Pharmaceutical Co., Ltd., Sandoz International GmbH, Ipsen Pharma, LG Chem, Merck KGaA, Genentech, Inc., Ferring B.V., AnkeBio Co., Ltd, Reliance Life Sciences, JCR Pharmaceuticals Co., Ltd, Zhongshan Sinobioway Hygene Biomedicine Co., Ltd and USV Private Limited
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global somatropin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global somatropin market

Detailed Segmentation:

Global Somatropin Market, By Dosage Form:
- Powder
- Solvent
Global Somatropin Market, By Application:
- Growth Hormone Deficiency (GHD)
- Turner Syndrome
- Chronic Renal Insufficiency
- Prader Willi Syndrome
- Small for Gestational Age
- SHOX Deficiency
- Others
Global Somatropin Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Somatropin Market, By Region:
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Novo Nordisk A/S
- Pfizer, Inc.
- Eli Lilly and Company
- Changchun Gene Science Pharmaceutical Co., Ltd.
- Sandoz International GmbH
- Ipsen Pharma
- LG Chem
- Merck KGaA
- Genentech, Inc.
- Ferring B.V.
- AnkeBio Co., Ltd
- Reliance Life Sciences
- JCR Pharmaceuticals Co., Ltd
- Zhongshan Sinobioway Hygene Biomedicine Co., Ltd
- USV Private Limited

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Dosage Form
  - Market Snapshot, By Application
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
  - Merger, Acquisition, Collaborations
  - Funding and Investment
  - Product Approvals/Launches
  - Regulatory Guidelines
  - Key Developments
  - PEST Analysis
  - PORTER’s Analysis
Global Somatropin Market– COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Somatropin Market, By Dosage Form, 2018-2030, (US$ Billion)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018-2030
  - Segment Trends
- Powder
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Solvent
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Global Somatropin Market, By Application, 2018-2030, (US$ Billion)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018-2030
  - Segments Trends
- Growth Hormone Deficiency (GHD)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Turner Syndrome
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Chronic Renal Insufficiency
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Prader Willi Syndrome
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Small for Gestational Age
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- SHOX Deficiency
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Global Somatropin Market, By Distribution Channel, 2018-2030, (US$ Billion)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018-2030
  - Segments Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Global Somatropin Market, By Region, 2018-2030, (US$ Billion)
- Introduction
  - Market Share Analysis, By Region, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Region, 2018–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Novo Nordisk A/S
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Changchun GeneScience Pharmaceutical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sandoz International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ipsen Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- LG Chem
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Genentech, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ferring B.V.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AnkeBio Co., Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Reliance Life Sciences
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- JCR Pharmaceuticals Co., Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zhongshan Sinobioway Hygene Biomedicine Co., Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- USV Private Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 32 market data tables and 36 figures on “Somatropin Market”- Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount